Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov;26(11):1987-1993.
doi: 10.1002/pon.4530. Epub 2017 Sep 18.

Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer

C Moynihan  1 , E K Bancroft  1   2 , A Mitra  1   3 , A Ardern-Jones  2 , E Castro  1   4 , E C Page  1 , R A Eeles  1   2
Affiliations

Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer

C Moynihan et al. Psychooncology. 2017 Nov.

Abstract

Objective: Increased risk of prostate cancer (PCa) is observed in men with BRCA1/BRCA2 mutations. Sex and gender are key determinants of health and disease although unequal care exists between the sexes. Stereotypical male attitudes are shown to lead to poor health outcomes.

Methods: Men with BRCA1/2 mutations and diagnosed with PCa were identified and invited to participate in a qualitative interview study. Data were analysed using a framework approach. "Masculinity theory" was used to report the impact of having both a BRCA1/2 mutation and PCa.

Results: Eleven of 15 eligible men were interviewed. The umbrella concept of "Ambiguity in a Masculine World" was evident. Men's responses often matched those of women in a genetic context. Men's BRCA experience was described, as "on the back burner" but "a bonus" enabling familial detection and early diagnosis of PCa. Embodiment of PCa took precedence as men revealed stereotypical "ideal" masculine responses such as stoicism and control while creating new "masculinities" when faced with the vicissitudes of having 2 gendered conditions.

Conclusion: Health workers are urged to take a reflexive approach, void of masculine ideals, a belief in which obfuscates men's experience. Research is required regarding men's support needs in the name of equality of care.

Keywords: BRCA1; BRCA2; gender/masculinity; prostate cancer; psychosocial.

PubMed Disclaimer

References

    1. Edwards SM, Kote‐Jarai Z, Meitz J, et al. Two percent of men with early‐onset prostate cancer harbour germline mutations in the BRCA2 gene. Am J Hum Genet. 2003;72(1):1‐12. - PMC - PubMed
    1. Castro E, Goh C, Olmos D, et al. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. J Clin Oncol. 2013;31:1748‐1757. - PMC - PubMed
    1. Leongamornlert D, Mahmud N, Tymrakiewicz M, et al. Germline BRCA1 mutations increase prostate cancer risk. Br J Cancer. 2012;106:1697‐1701. - PMC - PubMed
    1. Kote‐Jarai Z, Leongamornlert D, Saunders E, et al. BRCA2 is a moderate penetrance gene contributing to young‐onset prostate cancer: implications for genetic testing in prostate cancer patients. Br J Cancer. 2011;105:1230‐1234. - PMC - PubMed
    1. Moynihan C. Men, women, sex and gender. Eur J Cancer Care (Engl). 2002;3:166‐172. - PubMed